UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Islay Capital Management LLC

Islay Capital Management LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 16.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,352 shares of the healthcare conglomerate’s stock after purchasing an additional 324 shares during the quarter. UnitedHealth Group makes up approximately 1.0% of Islay Capital Management LLC’s holdings, making the stock its 29th largest holding. Islay Capital Management LLC’s holdings in UnitedHealth Group were worth $1,238,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Wellington Management Group LLP increased its holdings in UnitedHealth Group by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after purchasing an additional 527,526 shares during the last quarter. Northern Trust Corp increased its holdings in shares of UnitedHealth Group by 3.6% in the 3rd quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock valued at $4,934,895,000 after acquiring an additional 341,749 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of UnitedHealth Group by 2.2% in the 3rd quarter. Bank of New York Mellon Corp now owns 8,242,282 shares of the healthcare conglomerate’s stock valued at $4,155,676,000 after acquiring an additional 180,331 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of UnitedHealth Group by 0.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock valued at $2,937,976,000 after acquiring an additional 27,127 shares during the last quarter. Finally, Sanders Capital LLC increased its holdings in shares of UnitedHealth Group by 6.5% in the 3rd quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock valued at $2,902,829,000 after acquiring an additional 352,710 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 1.0 %

Shares of NYSE:UNH traded down $4.92 during midday trading on Tuesday, reaching $484.11. The company had a trading volume of 1,245,295 shares, compared to its average volume of 4,440,224. The company has a fifty day simple moving average of $485.19 and a two-hundred day simple moving average of $513.81. The firm has a market cap of $445.42 billion, a price-to-earnings ratio of 29.63, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the prior year, the business earned $6.26 EPS. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on UNH shares. Bank of America reiterated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Piper Sandler increased their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Finally, Royal Bank of Canada dropped their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.